Lactoferrin

An iron-binding glycoprotein of the transferrin family that sequesters iron (and potentially other metals) from pathogens at mucosal surfaces and sites of inflammation. Lactoferrin is a key effector of nutritional immunity, complementing calprotectin's role in metal restriction.

Structure and Metal Binding

Iron Binding

• Each lactoferrin molecule binds two Fe(III) ions with extremely high affinity (Kd ~10^-22 M), roughly 300-fold higher than transferrin.
• Iron binding is pH-dependent: lactoferrin retains iron at pH values as low as 3, allowing it to function in acidic environments (stomach, abscess cavities, vaginal mucosa).
• Iron-saturated lactoferrin (holo-lactoferrin) and iron-free lactoferrin (apo-lactoferrin) have distinct biological activities.

Potential Nickel Binding

• Lactoferrin contains histidine and tyrosine ligand residues that could coordinate Ni(II). A nickel-sequestering role is plausible but has not been experimentally confirmed ^[1].
• If validated, this would make lactoferrin a dual iron/nickel restriction factor at mucosal surfaces.

Distribution

• Breast milk: highest concentration (~7 mg/mL in colostrum, ~1-2 mg/mL in mature milk), providing neonatal innate immune defense.
• Mucosal secretions: saliva, tears, nasal secretions, vaginal fluid, seminal fluid, bronchial mucus.
• Neutrophil secondary granules: released at infection sites during degranulation, contributing to the metal-restricted abscess environment alongside calprotectin.
• Gut lumen: from dietary intake (breast milk) and neutrophil release during intestinal inflammation.

Lactoferrin and Vaginal Health

The Roberts et al. (2019) study provides the most detailed characterization of lactoferrin's mucosal immune function in a metallomics context:

• Vaginal lactoferrin concentrations increase dramatically with genital infections: 6.6-fold with bacterial vaginosis, 11.5-fold with Trichomonas vaginalis ^[2].
• Lactoferrin levels positively correlate with serum hepcidin (P = 0.047), serum ferritin (P = 0.018), and total body iron stores (P = 0.042) — suggesting coordinated systemic and mucosal iron restriction ^[2].
• Iron-deficient women had lower baseline lactoferrin, suggesting that iron deficiency compromises mucosal antimicrobial defense.
• Women with normal vaginal flora (Lactobacillus-dominant CST I) were more likely to be iron-replete.

Antimicrobial Mechanisms

Direct Iron Deprivation

• By binding free iron at mucosal surfaces, lactoferrin starves iron-dependent pathogens, inhibiting growth of gram-negative bacteria that require iron for siderophore-independent acquisition.

Beyond Iron Binding

• Lactoferricin (a peptide derived from lactoferrin digestion) has direct bactericidal activity via membrane disruption, independent of iron binding.
• Lactoferrin modulates immune cell function: enhances macrophage phagocytosis, promotes NK cell activity, and modulates cytokine production.
• Anti-biofilm activity: lactoferrin can disrupt early biofilm formation by iron-dependent pathogens.

Clinical Relevance

• IBD: Fecal lactoferrin, like fecal calprotectin, serves as a biomarker of intestinal inflammation ^[3].
• Neonatal protection: Breast milk lactoferrin is a major factor in neonatal gut immune defense; its absence in formula may contribute to increased infection risk and NEC.
• Heavy metal interaction: Heavy metals that disrupt iron homeostasis (Cd increases iron absorption via DMT1 upregulation in iron-depleted women) may indirectly impair lactoferrin-mediated defense ^[4].

Key Sources

• ^[5]

Connections

• iron — lactoferrin's primary metal target
• nutritional immunity — lactoferrin is a major mucosal effector
• hepcidin — coordinated systemic iron restriction
• calprotectin — complementary metal-sequestering protein (Zn/Mn/Ni-focused)
• gut metal microbiome — lactoferrin shapes microbial access to iron in the gut